Topics:

COPD

Drug Offers Novel Approach for Airway Diseases

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.
 

COPD

Long-acting beta-agonists offer benefits in COPD. Not true for inhaled corticosteroids for most, it turns out.

There is emergent need to improve recognition and management of COPD in HIV-infected patients. Details here.

SearchMedica News
Insights from a recent search on SearchMedica
 

A new study shows that the risk of chronic obstructive pulmonary disease increases with obesity. Yet, the risk was increased in underweight persons as well.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Pages

Subscribe to COPD on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.